STOCK TITAN

Dr. Chen Lichtenstein to lead ZIM (NYSE: ZIM) as new President and CEO

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

ZIM Integrated Shipping Services reported a leadership change, appointing Dr. Chen Lichtenstein as its new President and Chief Executive Officer. His appointment becomes effective on July 1, 2026, when he will also join ZIM’s Board of Directors, following the earlier resignation of CEO Eli Glickman on April 15, 2026.

The company notes that Dr. Lichtenstein’s employment agreement will be brought to shareholder approval as required by the Israeli Companies Law of 1999. ZIM highlights his extensive global leadership background, including senior roles at Syngenta Group, ADAMA Ltd., and Goldman Sachs, as well as current board responsibilities at Teva Pharmaceuticals and other international companies.

Management and board leaders emphasize that his mix of financial expertise, strategic insight, and experience guiding complex international organizations is expected to support ZIM’s operations across more than 90 countries and over 300 ports worldwide.

Positive

  • None.

Negative

  • None.

Insights

ZIM names a new CEO with deep global and financial experience.

ZIM is transitioning leadership by appointing Dr. Chen Lichtenstein as President and CEO effective July 1, 2026, following Eli Glickman’s resignation. The company underscores his background running complex international businesses and managing integration, growth, and capital structures.

This change concentrates experience from sectors like agricultural technology and chemicals into a container shipping context. The filing also states that his employment agreement will go to shareholders under the Israeli Companies Law of 1999, introducing a formal approval step that can shape final compensation terms.

Statements from the chairman and the CEO-appointee stress continuity of stability, performance, and value creation for stakeholders. Future company filings and communications can clarify his strategic priorities for ZIM’s global network of more than 90 countries and 300 ports.

CEO effective date July 1, 2026 Effective date of Dr. Lichtenstein’s appointment as President and CEO
CEO resignation date April 15, 2026 Resignation date of outgoing President and CEO Eli Glickman
Operations footprint more than 90 countries Scale of ZIM’s global operations
Customer base over 30,000 customers Number of customers served worldwide
Port coverage more than 300 ports Ports served by ZIM globally
Syngenta CFO tenure 2020 to 2023 Years Dr. Lichtenstein served as CFO at Syngenta Group
ADAMA CEO tenure 2014 to 2020 Years Dr. Lichtenstein served as President and CEO of ADAMA Ltd.
Form 6-K regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
President and Chief Executive Officer financial
"appointment of Dr. Chen Lichtenstein as its new President and Chief Executive Officer"
Board of Directors financial
"will also be joining its Board of Directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Israeli Companies Law of 1999 regulatory
"brought to shareholder approval as required by the Israeli Companies Law of 1999"
ESG values financial
"ZIM leverages digital strategies and a commitment to ESG values"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of June 2026

 

Commission File Number: 001-39937

 

ZIM Integrated Shipping Services Ltd. 

(Exact Name of Registrant as Specified in Its Charter)

 

9 Andrei Sakharov Street

P.O. Box 15067

Matam, Haifa 3190500, Israel

+972 (4) 865-2000

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F         Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes          No

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

  

Yes          No

 

 

 

On June 1, 2026, ZIM Integrated Shipping Services Ltd. (the “Company”) issued a press release. A copy of this press release is attached herewith as Exhibit 99.1.

 

The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ZIM INTEGRATED SHIPPING SERVICES LTD.
     
  By:   /s/ Noam Nativ
    Noam Nativ
    EVP General Counsel and Corporate Secretary

Date: June 1, 2026

 

 

EXHIBIT INDEX

 

EXHIBIT NO.   DESCRIPTION
99.1   Press Release dated June 1, 2026

 

 

 

 

 Exhibit 99.1

 

 

ZIM Board of Directors Appoints Dr. Chen Lichtenstein
as President and CEO of the Company; will also be
joining its Board of Directors

 

HAIFA, Israel, June 1, 2026 -- ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) (“ZIM” or the “Company”), a global container liner shipping company, announced today the appointment of Dr. Chen Lichtenstein as its new President and Chief Executive Officer following the resignation on April 15, 2026, of Eli Glickman, the existing President and Chief Executive Officer. The appointment of Dr. Lichtenstein will become effective as of July 1, 2026, at which time Dr. Lichtenstein will also become a member of the Board of Directors of the Company. The employment agreement between the Company and Dr. Lichtenstein will be brought to shareholder approval as required by the Israeli Companies Law of 1999.

 

Dr. Lichtenstein brings with him extensive management, business and financial experience in the global arena, including leading complex international companies, managing growth processes, integration and organizational change, operating in international markets and working with boards of directors, shareholders and global investment bodies.

 

From 2020 to 2023, he served as the Chief Financial Officer at Syngenta Group, a global agricultural technology company, and was also responsible for strategy, integration and productivity. In this role, he was a key partner in building the global group, which included Syngenta Seeds, Syngenta Crop Protection, ADAMA and the Group’s operations in China, and led significant steps towards growth, synergies, efficiency and management of a complex debt structure. Prior to his position at Syngenta Group, Dr. Lichtenstein served as the President and CEO of ADAMA Ltd. (formerly known as Makhteshim Agan Industries Ltd.) from 2014 to 2020, which he led during a period of significant, industry-leady growth, improved profitability and cash flow, integration with ChemChina’s operations, and a listing on the Shenzhen Stock Exchange. From 2013 to 2014, Dr. Lichtenstein also served as President and CEO of China National Agrochemical Corporation, ChemChina’s strategic agrochemical division, and parent of Syngenta Group. From 2006 to 2013 he served as the Deputy Chief Executive Officer, Head of Global Operations and held various other roles within Makhteshim Agan Industries, where he led, among other things, broad areas of activity including global operations, business development, integration in China, R&D, supply chain, purchasing and manufacturing. Previously Dr. Lichtenstein served as a senior investment banking executive at Goldman Sachs in New York and London from 1999 to 2006, where he led acquisition and financing transactions of significant scope.

 

 

Dr. Lichtenstein currently serves as a member of the Board of Directors at Teva Pharmaceuticals Ltd., as chairman of the board of directors at international companies in the fields of environmental sciences and biotechnology and as a senior advisor to international investment entities. Dr. Lichtenstein holds joint doctoral degrees from the Graduate School of Business and the School of Law at Stanford University, a B.Sc. in Physics from the Faculty of Mathematics and Natural Sciences, summa cum laude, and an LL.B. from the Faculty of Law, cum laude, at the Hebrew University of Jerusalem.

 

Dr. Lichtenstein was appointed following a search process, which was conducted on behalf of the ZIM Board of Directors, with the participation of the directors Yair Seroussi, the Chairman of the Board, Dr. Yoram Turbowicz and Yair Avidan.

 

Yair Seroussi, Chairman of the Board, stated, “Dr. Chen Lichtenstein is a highly experienced top-tier international executive, with a unique combination of extensive managerial experience, financial depth, strategic insight, and the ability to lead complex global organizations. His broad experience in managing international companies, working with global markets, shareholders, and boards of directors, together with his judgment and experience in leading transformation and integration processes, make him the right executive to lead ZIM at this time. We thank Eli Glickman for his significant contribution to the Company and wish Chen great success in his role.”

 

Dr. Lichtenstein, ZIM President and CEO-appointee stated, “I thank ZIM’s Board of Directors for its confidence and for the opportunity to lead a global Israeli company with a meaningful legacy, growth and business success, broad international operations, and outstanding people. ZIM operates in a dynamic, competitive, and complex market, and I attach great importance to maintaining the Company’s stability, strengthening its performance and business capabilities, and continuing to create value for customers, employees, partners, and shareholders.”

 

 

About ZIM

Founded in Israel in 1945, ZIM (NYSE: ZIM) is a leading global container liner shipping company with operations in more than 90 countries, serving over 30,000 customers across more than 300 ports worldwide. ZIM leverages digital strategies and a commitment to ESG values to provide customers innovative seaborne transportation and logistics services and exceptional customer experience. ZIM’s differentiated global-niche strategy, based on agile fleet management and deployment, covers major trade routes with a focus on select markets where the company holds competitive advantages. Additional information about ZIM is available at www.ZIM.com.

 

Investor Relations:

Elana Holzman
ZIM Integrated Shipping Services Ltd.
+972-4-865-2300
holzman.elana@zim.com

 

Leon Berman
The IGB Group
212-477-8438
lberman@igbir.com

 

Media:

Avner Shats
ZIM Integrated Shipping Services Ltd.
+972-4-865-2520
media@zim.com

 

 

 

 

FAQ

What leadership change did ZIM (ZIM) announce in this Form 6-K?

ZIM announced that Dr. Chen Lichtenstein has been appointed President and Chief Executive Officer, effective July 1, 2026. He will also join the Board of Directors, succeeding outgoing CEO Eli Glickman after his resignation on April 15, 2026.

When does ZIM’s new CEO, Dr. Chen Lichtenstein, take office?

Dr. Chen Lichtenstein’s appointment as ZIM’s President and CEO becomes effective on July 1, 2026. On that date he will also become a member of the Board of Directors, formalizing the leadership transition following Eli Glickman’s April 15, 2026 resignation.

Does ZIM require shareholder approval for the new CEO’s employment terms?

Yes. ZIM states that the employment agreement between the company and Dr. Chen Lichtenstein will be brought to shareholder approval. This is required under the Israeli Companies Law of 1999 and will govern his compensation and key employment conditions.

What is Dr. Chen Lichtenstein’s professional background before joining ZIM?

Dr. Lichtenstein previously served as Chief Financial Officer of Syngenta Group from 2020 to 2023 and President and CEO of ADAMA Ltd. from 2014 to 2020. He also held senior roles at China National Agrochemical Corporation and Goldman Sachs in New York and London.

How large is ZIM’s global shipping footprint mentioned in this report?

ZIM describes itself as a leading global container liner shipping company with operations in more than 90 countries. It serves over 30,000 customers across more than 300 ports worldwide, using digital strategies and an ESG-focused approach to deliver transportation and logistics services.

What strategic strengths does ZIM highlight about its business model?

ZIM highlights a differentiated global-niche strategy based on agile fleet management and deployment. The company focuses on major trade routes and select markets where it holds competitive advantages, combining digital tools and ESG commitments to support customer experience and logistics efficiency.

Filing Exhibits & Attachments

1 document